These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1577978)
21. [The immunocytochemical study of pleural effusion and ascites using Ber-EP-4 antibodies]. Spehn J; Iwanetz S; Schmitz-Huebner U Dtsch Med Wochenschr; 1995 Sep; 120(36):1197-200. PubMed ID: 7671771 [TBL] [Abstract][Full Text] [Related]
22. Immunological screening for tumor cells in serous body fluids has added value with the CELL-DYN Sapphire. Keuren JF; Hoffmann JJ; Leers MP Clin Chem Lab Med; 2014 Feb; 52(2):253-8. PubMed ID: 24096441 [TBL] [Abstract][Full Text] [Related]
23. A comparison of immunohistochemical staining of human cultured mesothelial cells and ovarian tumour cells using epithelial and mesothelial cell markers. Radford H; Wilson AP Anal Cell Pathol; 1996 Aug; 11(3):173-82. PubMed ID: 8888953 [TBL] [Abstract][Full Text] [Related]
25. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
26. Characterizing subpopulations of neoplastic cells in serous effusions. The role of immunocytochemistry. Queiroz C; Barral-Netto M; Bacchi CE Acta Cytol; 2001; 45(1):18-22. PubMed ID: 11213499 [TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183 [TBL] [Abstract][Full Text] [Related]
28. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions. Kundu R; Handa U; Mohan H Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027 [TBL] [Abstract][Full Text] [Related]
29. Flow cytometry in the detection of circulating tumor cells in neoplastic effusions. Gostomczyk K; Łukaszewska E; Borowczak J; Bator A; Zdrenka M; Bodnar M; Szylberg Ł Clin Chim Acta; 2024 Jan; 552():117651. PubMed ID: 37980974 [TBL] [Abstract][Full Text] [Related]
30. Measurement of placental alkaline phosphatase activity in benign and malignant pleural effusions. Fergusson RJ; Fisken J; McIntyre MA; Roulston JE; Leonard RC J Clin Pathol; 1992 Dec; 45(12):1114-5. PubMed ID: 1479040 [TBL] [Abstract][Full Text] [Related]
31. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases. Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861 [TBL] [Abstract][Full Text] [Related]
32. Different expression of FoxM1 in human benign and malignant pleural effusion. Tang Z; Li H; Zhu H; Bai C Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139 [TBL] [Abstract][Full Text] [Related]
33. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions. Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442 [TBL] [Abstract][Full Text] [Related]
34. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions]. Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134 [TBL] [Abstract][Full Text] [Related]
35. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions. Bassarova AV; Nesland JM; Davidson B Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of two strategies for the interpretation of tumour markers in pleural effusions. Trapé J; Sant F; Franquesa J; Montesinos J; Arnau A; Sala M; Bernadich O; Martín E; Perich D; Pérez C; Lopez J; Ros S; Esteve E; Pérez R; Aligué J; Gurt G; Catot S; Domenech M; Bosch J; Badal JM; Bonet M; Molina R; Ordeig J Respir Res; 2017 May; 18(1):103. PubMed ID: 28545517 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of metabolic phenotypes in malignant pleural effusions: expression of GLUT1 and CAIX by immunocytochemistry. Liao ND; Shieh JM; Lee WY Cancer Cytopathol; 2011 Oct; 119(5):346-53. PubMed ID: 21442770 [TBL] [Abstract][Full Text] [Related]
38. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions. Chen CJ; Chang SC; Tseng HH Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054 [TBL] [Abstract][Full Text] [Related]
39. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions. Barberis MC; Faleri M; Veronese S; Casadio C; Viale G Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions. Linari A; Bussolati G J Clin Pathol; 1989 Nov; 42(11):1184-9. PubMed ID: 2685053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]